Psychedelic Business Spotlight - May 20

Psychedelic Business Spotlight – May 20

,
This week in psychedelic business news: Another psychedelic merger; an Optimi Health acquisition; and good news for alcohol abuse treatment.

Psychedelic Business Spotlight – May 13

,
This week in psychedelic business news: Beckley Retreats set launch; another shark swims into the psychedelics industry; and MindMed shares promising LSD study results.

Psychedelic Business Spotlight – May 6

,
This week in psychedelic business news: Wesana Health pivots strategy; Compass Pathways makes progress on anorexia; Completion launches psychedelic VR NFTs.
Psychedelic Business Spotlight - April 29

Psychedelic Business Spotlight – April 29

,
This week in psychedelic business news: Field Trip Health splits in two, Tryp Therapeutics commences study, and Optimi Health celebrates new facility.

Psychedelic Business Spotlight – April 22

,
This week in psychedelic business news: Mindset Pharma files a new patent; Ehave's MetaHealthU app seeks to cure HPPD; Wellbeing Digital Sciences contemplates a sale.

Psychedelic Business Spotlight – April 15

,
This week in psychedelic business news: The industry's first major merger; NeonMind launches clinics; a portfolio of patents is acquired.
Psychedelic Business Spotlight - April 8

Psychedelic Business Spotlight – April 8

,
This week in psychedelic business news: Field Trip Health secures a patent; Core One Labs seeks more retail investors; a new CEO takes over GABA Therapeutics.

Psychedelic Business Spotlight – April 1

,
This week in psychedelic business news: TripSitter expands; Enveric files a major patent; and Psychedelic Water raises its profile.

Psychedelic Business Spotlight – March 25

,
This week in psychedelic business news: Filament Health scores 2nd psilocybin patent; a new psychedelics company emerges as one crumbles.
Psychedelic Business Spotlight - March 18

Psychedelic Business Spotlight – March 18

,
This week in psychedelic business news: A psychedelics company folds; Ketamine Wellness Centers expand; Nova Mentis funds psilocybin studies.